Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $42.7600 (-2.06%) ($42.7600 - $42.7600) on Mon. Jan. 11, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.24% (three month average) | RSI | 52 | Latest Price | $42.7600(-2.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.1% a day on average for past five trading days. | Weekly Trend | HALO advances 0.5% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(51%) IWM(49%) IWC(46%) ARKG(44%) | Factors Impacting HALO price | HALO will decline at least -1.62% in a week (0% probabilities). VIXM(-31%) VXX(-13%) UUP(-13%) IGOV(-3%) TLT(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.62% (StdDev 3.24%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $43.32(-1.29%) | 10 Day Moving Average | $42.93(-0.4%) | 20 Day Moving Average | $42.65(0.26%) | To recent high | -4.7% | To recent low | 52.8% | Market Cap | $5.844b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |